126 related articles for article (PubMed ID: 23728343)
1. A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF.
Borgdorff V; Rix U; Winter GE; Gridling M; Müller AC; Breitwieser FP; Wagner C; Colinge J; Bennett KL; Superti-Furga G; Wagner SN
Oncogene; 2014 May; 33(19):2531-9. PubMed ID: 23728343
[TBL] [Abstract][Full Text] [Related]
2. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
[TBL] [Abstract][Full Text] [Related]
3. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.
Feige E; Yokoyama S; Levy C; Khaled M; Igras V; Lin RJ; Lee S; Widlund HR; Granter SR; Kung AL; Fisher DE
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E924-33. PubMed ID: 21949374
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.
Yokoyama S; Feige E; Poling LL; Levy C; Widlund HR; Khaled M; Kung AL; Fisher DE
Pigment Cell Melanoma Res; 2008 Aug; 21(4):457-63. PubMed ID: 18627530
[TBL] [Abstract][Full Text] [Related]
6. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
Grabacka M; Placha W; Urbanska K; Laidler P; Płonka PM; Reiss K
Pigment Cell Melanoma Res; 2008 Jun; 21(3):388-96. PubMed ID: 18444964
[TBL] [Abstract][Full Text] [Related]
7. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
[TBL] [Abstract][Full Text] [Related]
10. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
[TBL] [Abstract][Full Text] [Related]
12. UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
Seo EY; Jin SP; Sohn KC; Park CH; Lee DH; Chung JH
J Invest Dermatol; 2017 Aug; 137(8):1757-1765. PubMed ID: 28392346
[TBL] [Abstract][Full Text] [Related]
13. A genomic screen identifies TYRO3 as a MITF regulator in melanoma.
Zhu S; Wurdak H; Wang Y; Galkin A; Tao H; Li J; Lyssiotis CA; Yan F; Tu BP; Miraglia L; Walker J; Sun F; Orth A; Schultz PG; Wu X
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17025-30. PubMed ID: 19805117
[TBL] [Abstract][Full Text] [Related]
14. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG
J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280
[TBL] [Abstract][Full Text] [Related]
15. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
[TBL] [Abstract][Full Text] [Related]
16. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.
Gelmi MC; Houtzagers LE; Strub T; Krossa I; Jager MJ
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682684
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia-associated transcription factor as the molecular target of cadmium toxicity in human melanocytes.
Chantarawong W; Takeda K; Sangartit W; Yoshizawa M; Pradermwong K; Shibahara S
Biochem Biophys Res Commun; 2014 Nov; 454(4):594-9. PubMed ID: 25449283
[TBL] [Abstract][Full Text] [Related]
18. Kazinol U inhibits melanogenesis through the inhibition of tyrosinase-related proteins via AMP kinase activation.
Lim J; Nam S; Jeong JH; Kim MJ; Yang Y; Lee MS; Lee HG; Ryu JH; Lim JS
Br J Pharmacol; 2019 Mar; 176(5):737-750. PubMed ID: 30579288
[TBL] [Abstract][Full Text] [Related]
19. MITF: master regulator of melanocyte development and melanoma oncogene.
Levy C; Khaled M; Fisher DE
Trends Mol Med; 2006 Sep; 12(9):406-14. PubMed ID: 16899407
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.
Kido K; Sumimoto H; Asada S; Okada SM; Yaguchi T; Kawamura N; Miyagishi M; Saida T; Kawakami Y
Cancer Sci; 2009 Oct; 100(10):1863-9. PubMed ID: 19659611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
